Global Rna Analysis Market

RNA Analysis Market Size, Share, Growth Analysis, By Technology(Real Time-PCR (qPCR) Technology, Microarray Technology), By Product(Instruments, Kits & Reagents), By Application(Construction of RNA Expression Atlas, Epigenetics) - Industry Forecast 2024-2031

Report ID: SQMIG35H2192 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 100 | Figures: 76

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

RNA Analysis Market size was valued at USD 15.5 billion in 2022 and is poised to grow from USD 16.12 billion in 2023 to USD 22.06 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).

The competitive landscape of the RNA analysis market is characterized by intense rivalry among established players and innovative entrants, all striving to carve a niche in this rapidly evolving domain. Major companies such as Thermo Fisher Scientific, Illumina, Inc., Agilent Technologies, and Qiagen AG dominate the market with their extensive product portfolios, advanced RNA sequencing platforms, and robust bioinformatics solutions. 'Thermo Fisher Scientific Inc. (USA)', 'Illumina, Inc. (USA)', 'Agilent Technologies, Inc. (USA)', 'Qiagen AG (Germany)', 'PerkinElmer, Inc. (USA)', 'Eurofins Scientific SE (Luxembourg)', 'Genewiz (a Brooks Life Sciences Company) (USA)', 'Bio-Rad Laboratories, Inc. (USA)', 'Merck KGaA (Germany)', 'Promega Corporation (USA)', 'Fluidigm Corporation (USA)', 'Oxford Nanopore Technologies Ltd. (United Kingdom)', 'Takara Bio Inc. (Japan)', 'Zymo Research Corporation (USA)', 'BGI Group (China)', 'NuGEN Technologies, Inc. (USA)', 'Lexogen GmbH (Austria)', 'Pacific Biosciences of California, Inc. (USA)', 'Roche Diagnostics (Switzerland)', 'Bio-Techne Corporation (USA)'

The pharmaceutical and biotech sectors heavily rely on RNA analysis to develop targeted therapies, personalized medicine, and innovative drug candidates. This has fueled substantial demand for RNA analysis techniques.

Long Read Sequencing: Advances in long-read sequencing technologies are enabling the accurate sequencing of full-length RNA molecules, enhancing the understanding of alternative splicing, isoforms, and complex gene structures.

In the year 2022, North America secured the largest market share, encompassing 44.10% of the total. This dominance can be attributed to the swift evolution of structure-based drug designs, an escalating emphasis on transcriptomics research, and substantial investments in biopharmaceutical research and development. Moreover, the pronounced uptick in financial allocations for pharmaceutical exploration and drug innovation significantly propels revenue growth for companies operating within this region. This dynamic landscape is fueled by the convergence of research and development initiatives, culminating in an amplified market presence.

Related Reports

Biopharmaceutical Analytical Testing Services Market
Buy Now GET FREE SAMPLE
Mutation Detection Kits In Genome Editing Market
Buy Now GET FREE SAMPLE
Induced Pluripotent Stem Cells Production Market
Buy Now GET FREE SAMPLE
Cancer Monoclonal Antibodies Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Rna Analysis Market

Product ID: SQMIG35H2192

$5,300
BUY NOW GET FREE SAMPLE